Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age
Clinical trial NCT00697554 · COMPLETED
Trial details
- NCT number
- NCT00697554
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-01-01
- Primary completion
- 2002-05-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.